|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/761 |
| (11) | Patento numeris | 3007711 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14736650.4 |
| Europos patento paraiškos padavimo data | 2014-06-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/062284 |
| Data | 2014-06-12 |
| (87) | Numeris | WO 2014/198852 |
| Data | 2014-12-18 |
| (30) | Numeris | Data | Šalis |
| 201310698 | 2013-06-14 | GB | |
| 201405140 | 2014-03-22 | GB | |
| 201406509 | 2014-04-10 | GB |
| (72) |
BEADLE, John, William, GB
FISHER, Kerry, GB
WILKINSON BLANC, Christine, GB
|
| (73) |
Psioxus Therapeutics Limited,
154B Milton Park, Abingdon, Oxfordshire OX14 4SD,
GB
|
| (54) | A DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES |
| A DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES |